| WKN: | A42086 |
| ISIN: | US45579U1097 |
| Land: | Großbritannien |
| Branche: | Chemie, Pharma, Bio- & Medizintechnik |
| Sektor: | Pharma |
Weshalb die Indivior-Aktie
ein B-Rating hat,
erfahren Sie im Performance-Check
vom 10. März 2026 Info.
| Rang | Datum | Vorjahr | Schluss | Performance |
|---|---|---|---|---|
| 1 | 2021 | 5,60 | 15,31 | 173,39% |
| 2 | 2025 | 11,70 | 30,00 | 156,41% |
| 3 | 2020 | 2,20 | 5,60 | 154,55% |
| 4 | 2015 | 9,03 | 12,75 | 41,20% |
| 5 | 2022 | 15,31 | 20,58 | 34,42% |
| 6 | 2017 | 16,90 | 22,70 | 34,32% |
| 7 | 2016 | 12,75 | 16,90 | 32,55% |
| 8 | 2026 | 30,00 | 27,76 | -7,47% |
| 9 | 2024 | 13,68 | 11,70 | -14,47% |
| 10 | 2023 | 20,58 | 13,68 | -33,53% |
| 11 | 2019 | 6,04 | 2,20 | -63,58% |
| 12 | 2018 | 22,70 | 6,04 | -73,39% |
| Rang | Datum | Vorjahr | Schluss | Performance |
|---|---|---|---|---|
| 1 | 2018 | 22,70 | 6,04 | -73,39% |
| 2 | 2019 | 6,04 | 2,20 | -63,58% |
| 3 | 2023 | 20,58 | 13,68 | -33,53% |
| 4 | 2024 | 13,68 | 11,70 | -14,47% |
| 5 | 2026 | 30,00 | 27,76 | -7,47% |
| 6 | 2016 | 12,75 | 16,90 | 32,55% |
| 7 | 2017 | 16,90 | 22,70 | 34,32% |
| 8 | 2022 | 15,31 | 20,58 | 34,42% |
| 9 | 2015 | 9,03 | 12,75 | 41,20% |
| 10 | 2020 | 2,20 | 5,60 | 154,55% |
| 11 | 2025 | 11,70 | 30,00 | 156,41% |
| 12 | 2021 | 5,60 | 15,31 | 173,39% |